University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Atropine suplhate 1% single use drops

Specialist ophthalmologist recommendation

Status: Amber Atropine tablets

For Myaesthenia Gravis only

Status: Amber Aveeno cream

Amber - oncology use

Green - paediatrics only

Status: Amber Aviptadil 25mcg / Phentolamine 2mg intracavernosal injection (Invicorp®)

Approved on formulary December 2017. Specialist initiation. Third line after oral PDE-5 inhibitors failed and patient not responding to or intolerant of alprostadil. To be reviewed within 12 months to assess alprostadil supply issues and patent expiry

Status: Amber Aymes® creme (semi-solid)
Status: Amber Azarga eye drops

Specialist ophthalmologist recommendation

Status: Amber Azathioprine

To be administered in conjunction with prednisolone (plain tablets). Supported by ESCA.

Status: Amber Azathioprine tablets

ESCA

Status: Amber Azathioprine#10.1

Supported by ESCA

Status: Amber Azathioprine#13.5

Azathioprine Dermatology ESCA

Building healthier lives
Back to top